Forma Therapeutics Holdings Inc. (FMTX) Social Stream
FORMA THERAPEUTICS HOLDINGS INC (FMTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering FMTX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-28 | 6 | $68.001 | $40 | $55.5 | $20.01 | 177.36% |
| 2021-12-17 | 6 | $68.001 | $37 | $52.666 | $20.01 | 163.2% |
| 2022-02-08 | 6 | $68.001 | $25 | $50.166 | $20.01 | 150.7% |
| 2022-03-02 | 6 | $68.001 | $25 | $48.166 | $20.01 | 140.71% |
| 2022-05-08 | 6 | $58 | $25 | $44.5 | $20.01 | 122.39% |
| 2022-05-09 | 6 | $58 | $25 | $43.666 | $20.01 | 118.22% |
| 2022-06-09 | 6 | $58 | $23 | $42.833 | $20.01 | 114.06% |
| 2022-07-27 | 6 | $58 | $21 | $38.666 | $20.01 | 93.23% |
| 2022-08-07 | 5 | $53 | $21 | $34.8 | $20.01 | 73.91% |
| 2022-08-23 | 5 | $53 | $23 | $34.6 | $20.01 | 72.91% |
| 2022-09-02 | 5 | $23 | $20 | $21.5 | $20.01 | 7.45% |
| 2022-09-06 | 5 | $23 | $20 | $20.75 | $20.01 | 3.7% |
The Trend in the Analyst Price Target
Over the past 27 weeks, FMTX's average price target has gone down $27.42.
Over the past 45 weeks, FMTX's average upside potential has been 363.05%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-17 | 6 | 68.001 | 37 | 52.666 | 14.54 | 262.21% |
| 2022-03-02 | 6 | 58.000 | 25 | 44.200 | 9.83 | 349.64% |
| 2022-04-01 | 6 | 58.000 | 25 | 44.500 | 9.99 | 345.45% |
| 2022-07-27 | 5 | 58.000 | 21 | 38.666 | 8.60 | 349.6% |
| 2022-07-27 | 6 | 58.000 | 21 | 38.666 | 8.60 | 349.6% |
FMTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.6 | 1 | 0 | 4 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 22 months, FMTX's average broker recommendation rating worsened by 1.6.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for FMTX as an investment opportunity.
- In the context of all US stocks, FORMA THERAPEUTICS HOLDINGS INC's variance in analysts' estimates is lower than -886.54% of them.
- In the context of all US stocks, FORMA THERAPEUTICS HOLDINGS INC's upside potential (average analyst target price relative to current price) is greater than 848.2% of them.
- In terms of how FORMA THERAPEUTICS HOLDINGS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 465% of that group.
- FMTX has a greater average analyst price target than 870.44% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to FORMA THERAPEUTICS HOLDINGS INC are FATE, EXAI, and ENZN.
View All Top Stocks by Price Target
Make investment decisions regarding FMTX using the data that counts. Try POWR Ratings for free.